Global Growth Trends in the Host Cell Protein Testing Market
The Host Cell Protein Testing Market is experiencing steady growth as biopharmaceutical production scales up worldwide. With a projected compound annual growth rate (CAGR) of over 5% through 2032, the market is driven by the increasing prevalence of chronic diseases, the expansion of biosimilar manufacturing, and rising regulatory scrutiny.Host cell proteins (HCPs) are process-related impurities from the cells used in biopharmaceutical production, and their detection is critical for ensuring product safety and efficacy. Key assay technologies such as ELISA, western blot, and mass spectrometry are evolving to offer higher sensitivity and throughput.North America currently leads the market due to its advanced biotech infrastructure, but Asia-Pacific is rapidly catching up, fueled by cost-effective manufacturing and strong government support. The demand for HCP testing will continue to surge as more biologics enter clinical and commercial phases.